News & Press Releases
Featured
ML Strategies Adds Highly Regarded Director of Government Relations in Boston
September 10, 2019
Filter by:
Cyber Standards for Connected Devices Leverage Federal Purchases
January 5, 2021 | Bloomberg Law
Vice President of ML Strategies Christian Fjeld was quoted in an article published by Bloomberg Law on how the Internet of Things Cybersecurity Improvement Act of 2020 may impact the industry due to the government’s purchasing power.
Internet of Things Law Uses Procurement Process to Boost Cybersecurity
December 8, 2020 | Westlaw
In Thomson Reuters’ Westlaw, Vice President of ML Strategies Christian Fjeld was quoted on the Internet of Things (IoT) Cybersecurity Improvement Act of 2020, which establishes security standards for IoT devices owned or controlled by the federal government and was recently signed into law by President Trump, and its potential “spillover effects” into the private sector.
Experts: HHS Review Proposal May Free Industry From Regulatory Red Tape
November 25, 2020 | Medtech Insight
In an article published by Medtech Insight, Senior Director of ML Strategies Aaron Josephson provided commentary on a recent proposal from the U.S. Department of Health and Human Services (HHS) to review regulations every 10 years and its potential impact on the medical device industry.
McClellan: Biden Admin Should Make FDA An Independent Agency
November 23, 2020 | Inside Health Policy
In an article published by Inside Health Policy, Mintz Member Joanne Hawana and Senior Director of ML Strategies Aaron Josephson commented on calls from industry leaders for the Biden administration to consider making the U.S. Food and Drug Administration (FDA) an independent agency, separate from the U.S. Department of Health and Human Services (HHS), which they assert would be unlikely to move very far in Congress.
Pharmaceutical Industry Wins in Divided Election
November 9, 2020 | POLITICO
Senior Director of ML Strategies Aaron Josephson was quoted in POLITICO on the U.S. Department of Health and Human Services’ proposed rule that would require its agencies, including the U.S. Food and Drug Administration, to review all regulations within two years and determine if any can be cut.
User Fees Will Be A Focus For Senate HELP, No Matter Who’s In Charge
November 5, 2020 | Inside Health Policy
An article published by Inside Health Policy featured extensive commentary from Senior Director of ML Strategies Aaron Josephson on priorities for the Senate Health, Education, Labor and Pensions (HELP) Committee following the 2020 Presidential election. Mintz Member Joanne Hawana was also quoted in the article.